Skip to main content
. 2020 Jan 6;10(1):e031156. doi: 10.1136/bmjopen-2019-031156

Table 2.

Details on benzodiazepine prescriptions, 2017

N % of all benzodiazepine prescriptions
Panel A: prescribed benzodiazepines ( n = 75 130 )
Anxiolitics (N05BA)
 Intermediate acting
  Lorazepam 29 945 39.9
  Oxazepam 12 298 16.4
  Alprazolam 5843 7.8
  Lorazepam+Diphenhydramine 1557 2.1
 Long acting
  Bromazepam 9840 13.1
  Clorazepate 3782 5.0
  Prazepam 1122 1.5
  Others (ie, diazepam, clobazam, kétazolam) 456 0.6
  Hypnotics and sedatives (N05CD)
 Short acting
  Midazolam 3524 4.7
  Triazolam 2039 2.7
 Intermediate acting
  Lormatezepam 755 1.0
  Temazepam 366 0.5
 Long acting
  Flurazepam 2461 3.3
  Flunitrazepam 838 1.1
  Nitrazepam 284 0.4
Mean SD Median IQR
Panel B: prescriptions among users ( n = 14 072 )
No. of benzodiazepine prescriptions 4.94 5.43 4 6
DDD 111.23 145.40 60 128
Mean daily dose 0.85 1.65 0.70 0.62
No. of different prescribers 1.25 0.57 1 0
No. of different drugs prescribed (any type)* 10.2 7.2 9 9
N %
No. of benzodiazepine prescriptions
 1 3839 27.3
 2–5 5278 37.5
 5–10 3427 24.4
 10+ 1528 10.9
DDD
 0–30 5046 35.9
 30–90 3371 24.0
 90–180 3142 22.3
 180–360 1713 12.2
 360+ 800 5.7
Estimated treatment duration (days)
 0–15 2936 20.1
 15–90 2095 14.9
 90–180 2182 15.5
 180–270 2440 17.3
 270+ 4419 31.4
Mean daily dose
 0–0.5 5317 37.8
 0.5–1 6893 50.0
 1–2 1429 10.2
 2+ 433 3.1

*Total number of prescriptions of different therapeutic/pharmacological subgroups (ATC 4-digit).

DDD, defined daily dose.